N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications - Quiz - MDSpire

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • By

  • Ming-Zhu Jin

  • Wen Di

  • June 29, 2026

  • 0 min

Share

Original Source(s)

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • by Ming-Zhu Jin, Wen Di

  • June 29, 2026

Related Content

Editorial: Novel insights into CAR T-cell associated neurotoxicity, volume II

Mixed adenoneuroendocrine carcinoma of the gallbladder: a case report and literature review

Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis